ID: ALA289650

Max Phase: Preclinical

Molecular Formula: C10H14O7

Molecular Weight: 246.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=C(OC)C(C(O)COC(C)=O)OC1=O

Standard InChI:  InChI=1S/C10H14O7/c1-5(11)16-4-6(12)7-8(14-2)9(15-3)10(13)17-7/h6-7,12H,4H2,1-3H3

Standard InChI Key:  RMWAIAGHLRZSSP-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-amylase 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.21Molecular Weight (Monoisotopic): 246.0740AlogP: -0.66#Rotatable Bonds: 5
Polar Surface Area: 91.29Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.49CX Basic pKa: CX LogP: -1.25CX LogD: -1.25
Aromatic Rings: 0Heavy Atoms: 17QED Weighted: 0.64Np Likeness Score: 1.79

References

1. Abell AD, Ratcliffe MJ, Gerrard J..  (1998)  Ascorbic acid-based inhibitors of alpha-amylases.,  (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4]

Source